Benzodiazepine Prescriptions Decline in US

October 2, 2026by Chris Aiken, MD5
Benzodiazepine use dropped by a quarter in a decade, but nurse practitioners now write twice as many

STUDY: Cruz N et al, American Journal of Psychiatry 2026

STUDY TYPE: Repeated cross-sectional study

FUNDING: Pew Charitable Trusts; Agency for Healthcare Research and Quality; National Institute on Drug Abuse

Background

Benzodiazepine prescribing climbed for two decades, then the FDA issued boxed warnings on combining them with opioids (2016) and on misuse and dependence (2020). This study looks at what happened next.

The Study
  • 1.1 billion benzodiazepine fills from a national pharmacy database covering about 90% of US retail prescriptions, 2013 to 2024.
  • Outcomes: the share of the population filling a benzodiazepine each year, fill counts by prescriber type, and dose per prescription.
Results

The share of Americans filling a benzodiazepine fell from 7.5% to 5.5%, a 27% drop. Adults 65 and older still had the highest rate (10.7% in 2024).

Young adults ages 18 to 29 saw the steepest decline (45%). Children ages 2 to 12 barely changed, because rising use of seizure drugs like clobazam offset declines in other benzodiazepines.

Prescriptions fell sharply among:

  • Pain specialists: 63% fewer
  • Primary care physicians: 44% fewer
  • Psychiatrists: 38% fewer

Prescriptions from nurse practitioners and physician assistants doubled, rising from 12% to 32% of all fills.

The average dose per prescription fell 18%. Psychiatrists prescribed the highest doses.

Practice Implications
  1. The NP and PA workforce significantly increased during this study, and the authors acknowledge that may create the appearance of an increase in scripts when it was an increase in clinicians.
  2. The study leaves an open question: Did NP and PA behavior change, or did more patients switch to these clinicians after MDs reduced their benzodiazepines?

—Chris Aiken, MD
Director, Psych Partners
Editor in Chief, Carlat Psychiatry Report

What’s Your Take? Share in Comments

5 comments

  • Dara

    October 11, 2026 at 8:46 pm

    I also think there’s a bigger practice-model question here. As practices hire more NPs and PAs to take over follow-ups and established patient panels, whose prescribing decisions are we actually measuring? The clinician signing the prescription may be continuing a treatment plan established by a physician, sometimes with that same physician still supervising the care. That doesn’t erase anyone’s individual responsibility, but it does make the ‘physicians prescribed less, NPs and PAs prescribed more’ framing more complicated. Are we seeing a change in prescribing behavior, or a change in who’s signing the prescriptions? This study doesn’t seem to answer that.

    Reply

    • Jillian

      October 17, 2026 at 4:15 am

      I agree with you. I have seen an increase that more businesses hiring NP’s and PA’s than MD’s. This study does not differentiate that.

      Reply

  • Lisa

    October 12, 2026 at 12:43 pm

    What is the percentage increase in service providers among APPs? And the change in ratio of services, by provider? I suspect there is no true increase among APPs; as younger providers we have been schooled to be cautious with benzos.

    Keep in mind that state controlled drug databases do not differentiate PAs by specialty.

    Reply

    • Chris Aiken, MD

      October 12, 2026 at 4:27 pm

      Those are important questions – the NP/PA workforce more than doubled since 2013, but the authors did not adjust the data for this

      Reply

  • Jeanette Houghtelling

    October 14, 2026 at 8:09 pm

    I can’t speak for all NP’s, but as a psych NP I often inherit patients who have developed benzo dependence – often in the context of polypharmacy. It takes a lot of time and diligence to deprescribe a medication profile that is harmful over the long term. When I initiate benzodiazepines, it’s generally used rarely and/or for a short time and specific purpose such as ETOH withdrawal or mania.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *